Compare RZLT & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RZLT | MVBF |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.4M | 329.1M |
| IPO Year | 2011 | 2004 |
| Metric | RZLT | MVBF |
|---|---|---|
| Price | $3.29 | $28.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $9.17 | ★ $27.60 |
| AVG Volume (30 Days) | ★ 2.8M | 40.0K |
| Earning Date | 05-27-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 2.44% |
| EPS Growth | ★ 26.32 | N/A |
| EPS | N/A | ★ 1.73 |
| Revenue | N/A | ★ $3,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $18.42 |
| P/E Ratio | ★ N/A | $16.18 |
| Revenue Growth | N/A | ★ 51.92 |
| 52 Week Low | $1.07 | $15.59 |
| 52 Week High | $11.46 | $29.59 |
| Indicator | RZLT | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 49.20 |
| Support Level | $3.16 | $27.41 |
| Resistance Level | $4.09 | $29.50 |
| Average True Range (ATR) | 0.31 | 0.99 |
| MACD | 0.06 | -0.16 |
| Stochastic Oscillator | 36.05 | 27.20 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.